B Acute Lymphoblastic Leukemia, BCR-ABL1-Like
Oncology·MeSH: Leukemia, Biphenotypic, Acute
Prevalence
30.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target B Acute Lymphoblastic Leukemia, BCR-ABL1-Like?
There are 1 clinical trial targeting B Acute Lymphoblastic Leukemia, BCR-ABL1-Like tracked by BioSniper.
What is the prevalence of B Acute Lymphoblastic Leukemia, BCR-ABL1-Like?
The estimated prevalence of B Acute Lymphoblastic Leukemia, BCR-ABL1-Like is approximately 30.0 per 100,000 population.
Deep-dive into B Acute Lymphoblastic Leukemia, BCR-ABL1-Like
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis